Tweet from UCSFHospitals at May 10, 2022 at 09:30AM
“It seems that #Paxlovid may benefit patients with #LongCOVID,” UCSF’s @MichaelPelusoMD says. Peluso and team found the drug helped several patients experiencing long COVID symptoms—but further rigorous studies are needed, he says. https://t.co/pBKX23eouQ
— UCSF Health (@UCSFHospitals)
May 10, 2022
from http://twitter.com/UCSFHospitals